annual operating profit:
-$321.39M+$55.35M(+14.69%)Summary
- As of today (July 1, 2025), TVTX annual operating income is -$321.39 million, with the most recent change of +$55.35 million (+14.69%) on December 31, 2024.
- During the last 3 years, TVTX annual operating profit has fallen by -$121.96 million (-61.16%).
- TVTX annual operating profit is now -2530522.05% below its all-time high of -$12.70 thousand, reached on February 28, 2011.
Performance
TVTX Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$42.67M+$16.66M(+28.08%)Summary
- As of today (July 1, 2025), TVTX quarterly operating income is -$42.67 million, with the most recent change of +$16.66 million (+28.08%) on March 31, 2025.
- Over the past year, TVTX quarterly operating profit has increased by +$96.30 million (+69.29%).
- TVTX quarterly operating profit is now -1422366.67% below its all-time high of -$3000.00, reached on May 31, 2011.
Performance
TVTX quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$225.09M+$96.30M(+29.96%)Summary
- As of today (July 1, 2025), TVTX TTM operating income is -$225.09 million, with the most recent change of +$96.30 million (+29.96%) on March 31, 2025.
- Over the past year, TVTX TTM operating profit has increased by +$193.27 million (+46.20%).
- TVTX TTM operating profit is now -7260706.45% below its all-time high of -$3100.00, reached on November 30, 2010.
Performance
TVTX TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
TVTX Operating profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +14.7% | +69.3% | +46.2% |
3 y3 years | -61.2% | +25.2% | -3.5% |
5 y5 years | -222.0% | -151.2% | -203.4% |
TVTX Operating profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -61.2% | +14.7% | at high | +69.3% | at high | +46.2% |
5 y | 5-year | -326.4% | +14.7% | -197.4% | +69.3% | -225.7% | +46.2% |
alltime | all time | <-9999.0% | +14.7% | <-9999.0% | +69.3% | <-9999.0% | +46.2% |
TVTX Operating profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$42.67M(-28.1%) | -$225.09M(-30.0%) |
Dec 2024 | -$321.39M(-14.7%) | -$59.33M(+5.9%) | -$321.39M(-6.8%) |
Sep 2024 | - | -$56.03M(-16.4%) | -$344.89M(-9.6%) |
Jun 2024 | - | -$67.05M(-51.8%) | -$381.45M(-8.8%) |
Mar 2024 | - | -$138.98M(+67.8%) | -$418.35M(+11.0%) |
Dec 2023 | -$376.74M(+17.8%) | -$82.84M(-10.5%) | -$376.74M(-1.0%) |
Sep 2023 | - | -$92.58M(-10.9%) | -$380.61M(+2.7%) |
Jun 2023 | - | -$103.95M(+6.8%) | -$370.63M(+13.3%) |
Mar 2023 | - | -$97.37M(+12.3%) | -$327.22M(+14.1%) |
Dec 2022 | -$319.81M(+60.4%) | -$86.70M(+5.0%) | -$286.90M(-7.2%) |
Sep 2022 | - | -$82.60M(+36.4%) | -$309.01M(+26.5%) |
Jun 2022 | - | -$60.54M(+6.1%) | -$244.25M(+12.3%) |
Mar 2022 | - | -$57.05M(-47.6%) | -$217.51M(+9.1%) |
Dec 2021 | -$199.43M(+164.6%) | -$108.81M(+509.7%) | -$199.43M(+72.2%) |
Sep 2021 | - | -$17.85M(-47.2%) | -$115.83M(+3.1%) |
Jun 2021 | - | -$33.81M(-13.2%) | -$112.33M(+15.4%) |
Mar 2021 | - | -$38.96M(+54.5%) | -$97.35M(+29.2%) |
Dec 2020 | -$75.38M(-24.5%) | -$25.21M(+75.7%) | -$75.38M(+9.1%) |
Sep 2020 | - | -$14.35M(-23.8%) | -$69.10M(-6.9%) |
Jun 2020 | - | -$18.82M(+10.8%) | -$74.19M(-16.2%) |
Mar 2020 | - | -$16.99M(-10.3%) | -$88.54M(-10.7%) |
Dec 2019 | -$99.81M(+45.3%) | -$18.94M(-2.6%) | -$99.11M(+3.0%) |
Sep 2019 | - | -$19.44M(-41.4%) | -$96.20M(+0.5%) |
Jun 2019 | - | -$33.18M(+20.4%) | -$95.74M(+16.8%) |
Mar 2019 | - | -$27.56M(+72.0%) | -$81.97M(+19.3%) |
Dec 2018 | -$68.69M(+123.1%) | -$16.02M(-15.6%) | -$68.69M(+17.4%) |
Sep 2018 | - | -$18.98M(-2.2%) | -$58.52M(+31.3%) |
Jun 2018 | - | -$19.40M(+35.8%) | -$44.58M(+25.6%) |
Mar 2018 | - | -$14.29M(+144.3%) | -$35.49M(+10.0%) |
Dec 2017 | -$30.79M | -$5.85M(+15.9%) | -$32.27M(-11.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$5.05M(-51.1%) | -$36.59M(-20.9%) |
Jun 2017 | - | -$10.31M(-6.8%) | -$46.27M(+3.9%) |
Mar 2017 | - | -$11.06M(+8.8%) | -$44.54M(+14.1%) |
Dec 2016 | -$38.94M(+20.7%) | -$10.17M(-30.9%) | -$39.02M(+4.6%) |
Sep 2016 | - | -$14.72M(+71.4%) | -$37.31M(+18.6%) |
Jun 2016 | - | -$8.59M(+54.9%) | -$31.47M(+5.9%) |
Mar 2016 | - | -$5.55M(-34.4%) | -$29.70M(-7.9%) |
Dec 2015 | -$32.26M(-59.6%) | -$8.45M(-4.8%) | -$32.26M(-24.1%) |
Sep 2015 | - | -$8.88M(+30.1%) | -$42.51M(-23.4%) |
Jun 2015 | - | -$6.82M(-15.8%) | -$55.49M(-15.7%) |
Mar 2015 | - | -$8.10M(-56.7%) | -$65.85M(-17.5%) |
Dec 2014 | -$79.81M(+222.2%) | -$18.70M(-14.5%) | -$79.81M(+8.8%) |
Sep 2014 | - | -$21.87M(+27.3%) | -$73.38M(+29.5%) |
Jun 2014 | - | -$17.18M(-22.1%) | -$56.67M(+27.1%) |
Mar 2014 | - | -$22.06M(+79.8%) | -$44.58M(+82.7%) |
Dec 2013 | -$24.77M(-18.1%) | -$12.27M(+138.0%) | -$24.41M(+101.0%) |
Sep 2013 | - | -$5.15M(+1.1%) | -$12.14M(+73.7%) |
Jun 2013 | - | -$5.10M(+170.5%) | -$6.99M(+269.0%) |
Mar 2013 | - | -$1.89M(>+9900.0%) | -$1.89M(>+9900.0%) |
Dec 2012 | -$30.26M(>+9900.0%) | - | - |
Nov 2012 | - | -$3200.00(+6.7%) | -$13.00K(+1.6%) |
Aug 2012 | - | -$3000.00(0.0%) | -$12.80K(0.0%) |
May 2012 | - | -$3000.00(-21.1%) | -$12.80K(0.0%) |
Feb 2012 | - | -$3800.00(+26.7%) | -$12.80K(+1.6%) |
Feb 2012 | -$12.80K(+0.8%) | - | - |
Nov 2011 | - | -$3000.00(0.0%) | -$12.60K(-0.8%) |
Aug 2011 | - | -$3000.00(0.0%) | -$12.70K(+30.9%) |
May 2011 | - | -$3000.00(-16.7%) | -$9700.00(+44.8%) |
Feb 2011 | -$12.70K | -$3600.00(+16.1%) | -$6700.00(+116.1%) |
Nov 2010 | - | -$3100.00 | -$3100.00 |
FAQ
- What is Travere Therapeutics annual operating income?
- What is the all time high annual operating profit for Travere Therapeutics?
- What is Travere Therapeutics annual operating profit year-on-year change?
- What is Travere Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Travere Therapeutics?
- What is Travere Therapeutics quarterly operating profit year-on-year change?
- What is Travere Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Travere Therapeutics?
- What is Travere Therapeutics TTM operating profit year-on-year change?
What is Travere Therapeutics annual operating income?
The current annual operating profit of TVTX is -$321.39M
What is the all time high annual operating profit for Travere Therapeutics?
Travere Therapeutics all-time high annual operating income is -$12.70K
What is Travere Therapeutics annual operating profit year-on-year change?
Over the past year, TVTX annual operating income has changed by +$55.35M (+14.69%)
What is Travere Therapeutics quarterly operating income?
The current quarterly operating profit of TVTX is -$42.67M
What is the all time high quarterly operating profit for Travere Therapeutics?
Travere Therapeutics all-time high quarterly operating income is -$3000.00
What is Travere Therapeutics quarterly operating profit year-on-year change?
Over the past year, TVTX quarterly operating income has changed by +$96.30M (+69.29%)
What is Travere Therapeutics TTM operating income?
The current TTM operating profit of TVTX is -$225.09M
What is the all time high TTM operating profit for Travere Therapeutics?
Travere Therapeutics all-time high TTM operating income is -$3100.00
What is Travere Therapeutics TTM operating profit year-on-year change?
Over the past year, TVTX TTM operating income has changed by +$193.27M (+46.20%)